Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

The expression of Eg5 predicts a poor outcome for patients with renal cell carcinoma.

Sun D, Lu J, Ding K, Bi D, Niu Z, Cao Q, Zhang J, Ding S.

Med Oncol. 2013 Mar;30(1):476. doi: 10.1007/s12032-013-0476-0. Epub 2013 Feb 1.

PMID:
23371254
2.

Expression of endothelin 2 and localized clear cell renal cell carcinoma.

Bot BM, Eckel-Passow JE, LeGrand SN, Hilton T, Cheville JC, Igel T, Parker AS.

Hum Pathol. 2012 Jun;43(6):843-9. doi: 10.1016/j.humpath.2011.07.011. Epub 2011 Nov 1.

3.

Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival.

Qin J, Yang B, Xu BQ, Smithc A, Xu L, Yuan JL, Li L.

Int J Clin Exp Pathol. 2014 May 15;7(6):3235-44. eCollection 2014.

4.

Overexpression of Eg5 predicts unfavorable prognosis in non-muscle invasive bladder urothelial carcinoma.

Ding S, Xing N, Lu J, Zhang H, Nishizawa K, Liu S, Yuan X, Qin Y, Liu Y, Ogawa O, Nishiyama H.

Int J Urol. 2011 Jun;18(6):432-8. doi: 10.1111/j.1442-2042.2011.02751.x. Epub 2011 Mar 30.

5.

Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.

Petraki CD, Gregorakis AK, Vaslamatzis MM, Papanastasiou PA, Yousef GM, Levesque MA, Diamandis EP.

Tumour Biol. 2006;27(1):1-7. Epub 2005 Dec 8.

PMID:
16340244
6.

Expression of IL-4 and IL-13 predicts recurrence and survival in localized clear-cell renal cell carcinoma.

Chang Y, Xu L, An H, Fu Q, Chen L, Lin Z, Xu J.

Int J Clin Exp Pathol. 2015 Feb 1;8(2):1594-603. eCollection 2015.

7.

High expression of APRIL correlates with poor prognosis in clear cell renal cell carcinoma.

Lee C, Park JW, Suh JH, Moon KC.

Pathol Res Pract. 2015 Nov;211(11):824-8. doi: 10.1016/j.prp.2015.07.011. Epub 2015 Jul 20.

PMID:
26296917
8.

Increased expression of Chitinase 3-like 1 and microvessel density predicts metastasis and poor prognosis in clear cell renal cell carcinoma.

Zhang JP, Yuan HX, Kong WT, Liu Y, Lin ZM, Wangs WP, Guo JM.

Tumour Biol. 2014 Dec;35(12):12131-7. doi: 10.1007/s13277-014-2518-4. Epub 2014 Aug 21.

PMID:
25142236
9.

Increased expression of forkhead box M1 protein is associated with poor prognosis in clear cell renal cell carcinoma.

Wu XR, Chen YH, Liu DM, Sha JJ, Xuan HQ, Bo JJ, Huang YR.

Med Oncol. 2013 Mar;30(1):346. doi: 10.1007/s12032-012-0346-1. Epub 2012 Dec 22.

PMID:
23263830
10.

Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma.

Sgambato A, Camerini A, Amoroso D, Genovese G, De Luca F, Cecchi M, Migaldi M, Rettino A, Valsuani C, Tartarelli G, Donati S, Siclari O, Rossi G, Cittadini A.

Cancer Biol Ther. 2007 Dec;6(12):1840-6. Epub 2007 Sep 5.

PMID:
18087214
11.

Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.

Pan D, Xu L, Liu H, Zhang W, Zhu Y, Xu J, Gu J.

Jpn J Clin Oncol. 2015 Feb;45(2):202-9. doi: 10.1093/jjco/hyu194. Epub 2014 Nov 23.

PMID:
25420690
12.

Feline sarcoma-related protein expression correlates with malignant aggressiveness and poor prognosis in renal cell carcinoma.

Miyata Y, Kanda S, Sakai H, Greer PA.

Cancer Sci. 2013 Jun;104(6):681-6. doi: 10.1111/cas.12140. Epub 2013 Apr 18.

13.

Klotho suppresses tumor progression via inhibiting PI3K/Akt/GSK3β/Snail signaling in renal cell carcinoma.

Zhu Y, Xu L, Zhang J, Xu W, Liu Y, Yin H, Lv T, An H, Liu L, He H, Zhang H, Liu J, Xu J, Lin Z.

Cancer Sci. 2013 Jun;104(6):663-71. doi: 10.1111/cas.12134. Epub 2013 Mar 29.

14.

Increased BTB-Kelch type substrate adaptor protein immunoreactivity associates with advanced stage and poor differentiation in renal cell carcinoma.

Ronkainen H, Vaarala MH, Kauppila S, Soini Y, Paavonen TK, Rask J, Hirvikoski P.

Oncol Rep. 2009 Jun;21(6):1519-23.

PMID:
19424632
15.

Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.

Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS.

Am J Surg Pathol. 1997 Jun;21(6):621-35.

PMID:
9199639
16.

Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view.

May M, Brookman-Amissah S, Roigas J, Gilfrich CP, Pflanz S, Hoschke B, Gunia S.

Urol Oncol. 2010 May-Jun;28(3):274-9. doi: 10.1016/j.urolonc.2008.07.008. Epub 2008 Sep 21.

PMID:
18805709
17.

Osteopontin but not parathyroid hormone-related protein predicts prognosis in human renal cell carcinoma.

Papworth K, Bergh A, Grankvist K, Ljungberg B, Sandlund J, Rasmuson T.

Acta Oncol. 2013 Jan;52(1):159-65. doi: 10.3109/0284186X.2012.693623. Epub 2012 Jun 26.

PMID:
22731830
18.

Elevated Expression of N-Acetylgalactosaminyltransferase 10 Predicts Poor Survival and Early Recurrence of Patients with Clear-Cell Renal Cell Carcinoma.

Wu Q, Yang L, Liu H, Zhang W, Le X, Xu J.

Ann Surg Oncol. 2015 Jul;22(7):2446-53. doi: 10.1245/s10434-014-4236-y. Epub 2014 Nov 13.

PMID:
25391266
19.

Anillin expression is a marker of favourable prognosis in patients with renal cell carcinoma.

Ronkainen H, Hirvikoski P, Kauppila S, Vaarala MH.

Oncol Rep. 2011 Jan;25(1):129-33.

PMID:
21109967
20.

High expression of Twist is associated with tumor aggressiveness and poor prognosis in patients with renal cell carcinoma.

Ohba K, Miyata Y, Matsuo T, Asai A, Mitsunari K, Shida Y, Kanda S, Sakai H.

Int J Clin Exp Pathol. 2014 May 15;7(6):3158-65. eCollection 2014.

Supplemental Content

Support Center